Logo

Lung Cancer

News and reporting on lung cancer.

Biodesix Raises Approximately $16.3M in Sale of Common Shares, Amends $30M Term Loan

The term loan amendment includes modifications to restrictive financial covenants to provide the firm with additional financial flexibility.

Genecast Minimal Residual Disease Test Plans Bolstered by New Lung Cancer Data
Premium

The company believes its fixed-panel, informatically guided approach can help capture the most possible patients with signs of residual or recurring cancer.

GE Healthcare Precision Oncology Pacts Focus on Cracking Data Silos, Improving Patient Outcomes
Premium

GE recently inked deals with Sophia Genetics, the University of Cambridge, and Optellum to improve early diagnosis of cancer with genomics and AI.

Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests

Startup Spesana's digital platform will integrate EMR, lab information, and MDx data to automate clinical workflows, tumor boards, and clinical trial management.

BioMark Diagnostics, AstraZeneca, Pfizer, Others Partner in Lung Cancer Screening Project

The collaborators aim to develop tools that combine AI with radiomic, genetic, and metabolomic biomarkers for lung cancer screening.

Nov 22, 2021

Cancer Dx Firms ACT Genomics, Sanomics Merge

Nov 19, 2021

Postsurgical ctDNA Analysis Predicts Adjuvant Chemotherapy Benefit in NSCLC

Nov 17, 2021

Burning Rock Details Launch Plans for Three New Oncology Assays in 2022
Premium

Nov 16, 2021

BioMark Diagnostics Nabs Canadian Funding for Lung Cancer Liquid Biopsy

Oct 13, 2021

MiRxes to Expand miRNA Assay Technology to Multiple Cancer Types, Other Disease Areas
Premium

Oct 7, 2021

Angle Readies for Clinical Testing as CTC Research Continues to Yield Biomarker Insights
Premium

Oct 7, 2021

Lung Cancer Treatment Response Linked to Cancer-Associated Fibroblast Cell Subtypes

Sep 16, 2021

Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features

Sep 16, 2021

FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC

Sep 7, 2021

Lung Cancers in Non-Smokers Fall Into Informative Molecular Subtypes

Aug 27, 2021

Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech
Premium

Aug 27, 2021

Oncocyte Launches Prospective Registry to Drive DetermaRx Adoption, Improve Coverage
Premium

Aug 19, 2021

Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan

Aug 17, 2021

Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko

Aug 10, 2021

Oncocyte Sees $2M in Q2 Revenues, Beating Wall Street Estimate

Aug 5, 2021

Lung Cancer Features, Treatment Clues Emerge From 'Omic Analysis of Difficult-to-Treat Subtype

Aug 5, 2021

Pillar Biosciences Receives FDA Approval for OncoReveal Dx Lung and Colon Cancer Assay

Jul 29, 2021

Veracyte Q2 Revenues More Than Double on Test Volume Spike

Jul 16, 2021

FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC

Jul 13, 2021

Genetron Health Receives CE Mark for Lung Cancer Sequencing Assay

Breaking News
The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.